Michel Vanbrabant

Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ

KBC Asset Management NV (KBC AM) is the wholly-owned asset management subsidiary of KBC Bank NV, itself a subsidiary of KBC Group SA/NV (XB: KBC; ADR: KBCSY) in Belgium. The firm was founded in 2000 and is previously a division of KBC Bank. Headquartered in Brussels, KBC AM provides asset management services to private individuals, corporate clients and institutions. They also manage a range of mutual funds across various asset classes, markets and strategies.

Nexus Dx, Inc. engages in the provision of of a near patient testing system and advanced diagnostic solution. Its offers point-of-care (POC) immunoassay, IB10 analyzer system, and tests for established critical care parameters. The company was founded on January 16, 2009 and is headquartered in San Diego, CA.

LMS International NV specializes in software and engineering services for the automotive, aerospace and manufacturing industries. It provides test and mechatronic simulation software, which includes model-based systems engineering to the automotive, aerospace, and other advanced manufacturing industries. The company was founded in 1980 and is headquartered in Leuven, Belgium.

Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium.

Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium.

Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada.

Part of Goodyear Tire & Rubber Co., Goodyear Europe BV is a Dutch tire company that offers high-performance and safe tires. The company is based in Vianen, Netherlands. The company's tires are the result of over 100 years of innovation and the latest technologies, providing exceptional performance and safety. If the text is non-English, it states that the company's tires are the result of more than 100 years of innovation and modern technologies, ensuring high levels of performance and safety. Goodyear Europe was acquired by Goodyear Tire & Rubber Co. on October 01, 2015.

Goodyear SA engages in the manufacturing of tires equipment. The company is headquartered in Luxembourg.

PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ.

Capricorn Health-Tech Fund NV invests in companies located in Western Europe. It targets companies operating in the fields of human health-technology. It provides financing for seed stage, early stage and growth stage in equity and debt with an investment size between EUR 0.5 million and EUR 6 million. It acquires mostly minority stakes but also majority stakes.

PhysIOL SA develops and manufactures intraocular lenses. It offers multifocal IOL, toric IOL, hydrophobic IOL, preloaded IOL, injection systems, viscoelastics and other surgical products. The firm's services include polymer chemistry through to sterilization processes, including modeling and risk-control associated with implantable materials. The company was founded in 1986 and is headquartered in Liege, Belgium.

Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium.

Cathvision ApS provides therapy for arrhythmia technology. Its products include cathvision, system specs, EP labs and EP lab instrumentation. The company was founded by Mads Emil Matthiesen and Rune Justesen Orndrup in 2010 and is headquartered in Copenhagen, Denmark.

Cardiawave SA develops non-invasive medical device to treat a heart condition called aortic stenosis. The company was founded by Emmanuel Messas, Benjamin Bertrand, Mickaël Tanter, Mathieu Pernot and Mathias Fink on October 21, 2014 and is headquartered in Paris, France.

Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland.

Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.

Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark.

Atlantic Therapeutics Ltd. is a medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products. The firm offers INNOVO products. The company is headquartered in Galway, Ireland.

Part of Triley Bidco Ltd., iQone Healthcare Holding provides pharmaceutical services. The company is based in Geneva, Switzerland. The Swiss company was founded in 1979. iQone Healthcare Holding was acquired by Clinigen Ltd., part of Triley Bidco Ltd. from April 04, 2022 on October 09, 2018 for $8.68 million.

Pathway Diagnostics Ltd. provides clinical diagnostic products and medical instrumentation services. Its products include haemostasis, autoimmune and allergy, complement system, bone and cartilage, metabolic syndrome, organ injury, oncology and toxicology. The company was founded in 1999 and is headquartered in Dorking, the United Kingdom.

Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland.

Sprig Equity Management LLC (Sprig Equity Management) is a private equity and venture capital firm founded in 2022 by Norton Evan and Arnold Kathryn. The firm is headquartered in Wilmette, Illinois.